Clinical Trial Update: Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. [Phase 1]

View source ↗

Summary

Phase 1 study of BA3182 in patients with adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma

Drugs mentioned

• BA3182

Snippet

Sponsor: BioAtla, Inc. | Conditions: Advanced Adenocarcinoma | Phase 1 | Status: RECRUITING